SGLT inhibitors on weight and body mass: A meta‐analysis of 116 randomized‐controlled trials-Reference-Cited by-同舟云学术

SGLT inhibitors on weight and body mass: A meta‐analysis of 116 randomized‐controlled trials

Published:2021-12-21 Issue:1 Volume:30 Page:117-128
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Cheong Alex Jia Yang¹^ORCID,Teo Yao Neng¹^ORCID,Teo Yao Hao¹^ORCID,Syn Nicholas L.¹^ORCID,Ong How Ting¹^ORCID,Ting Adriel Z. H.¹^ORCID,Chia Alys Z. Q.¹^ORCID,Chong Elliot Yeung¹^ORCID,Chan Mark Y.¹²^ORCID,Lee Chi‐Hang¹²^ORCID,Lim Amanda Yuan Ling³^ORCID,Kong William K. F.¹²^ORCID,Wong Raymond C. C.¹²^ORCID,Chai Ping¹²^ORCID,Sia Ching‐Hui¹²^ORCID

Affiliation:

1. Department of Medicine Yong Loo Lin School of Medicine National University of Singapore Singapore

2. Department of Cardiology National University Heart Centre Singapore Singapore

3. Division of Endocrinology University Medicine Cluster National University Health System (NUHS) Singapore

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.23331

Reference42 articles.

1. World Health Organization.Obesity and overweight. Updated June 9 2021. Accessed May 8 2021.https://www.who.int/en/news‐room/fact‐sheets/detail/obesity‐and‐overweight

2. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK

3. Obesity in COVID-19: A Systematic Review and Meta-analysis

4. Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction: The role of inflammation;European Journal of Pharmacology;2024-10

2. Effects of weight loss from oral semaglutide administration on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a retrospective analysis using propensity score matching;Diabetology International;2024-07-31

3. Body weight change associated kidney outcomes of sodium–glucose cotransporter new users;Diabetes, Obesity and Metabolism;2024-07-28

4. Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Transcription Regulation of AgRP and POMC Genes;Current Issues in Molecular Biology;2024-07-15

5. Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07-08